Howard Brown Health, Chicago IL; and.
Department of Medicine, University of Chicago, Chicago IL.
J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):166-171. doi: 10.1097/QAI.0000000000002833.
HIV pre-exposure prophylaxis (PrEP) requires continued use at an effective dosage to reduce HIV incidence. Data suggest early PrEP drop-off among many populations. We sought to describe PrEP use over the first year among racial and ethnic minority patients in the US.
Racial and ethnic minority patients initiating PrEP at a federally qualified health center in Chicago, IL.
Using electronic health records, we determined the adherence (≥6 weekly doses) trajectories over the first year of PrEP use and compared baseline and time-varying patient characteristics.
From 2159 patients, we identified 3 PrEP use trajectories. Sustained use was the most common (40%) trajectory, followed by short use (30%) and declining use (29%). In adjusted models, younger age, Black race, as well as gender, sexual orientation, insurance status at baseline, and neighborhood were associated with trajectory assignment; within some trajectories, insurance status during follow-up was associated with odds of monthly adherence (≥6 weekly doses).
Among racial and ethnic minorities, a plurality achieved sustained PrEP persistence. Access to clinics, insurance, and intersectional stigmas may be modifiable barriers to effective PrEP persistence; in addition, focus on younger users and beyond gay, cismale populations are needed.
艾滋病毒暴露前预防(PrEP)需要持续使用有效剂量以降低艾滋病毒感染率。数据表明,许多人群的 PrEP 使用率都在早期下降。我们旨在描述美国少数族裔患者在第一年使用 PrEP 的情况。
在伊利诺伊州芝加哥的一家联邦合格的健康中心开始接受 PrEP 的少数族裔患者。
我们使用电子健康记录确定了第一年 PrEP 使用期间的依从性(≥6 剂/周)轨迹,并比较了基线和随时间变化的患者特征。
从 2159 名患者中,我们确定了 3 种 PrEP 使用轨迹。持续使用是最常见的(40%)轨迹,其次是短期使用(30%)和递减使用(29%)。在调整后的模型中,年龄较小、黑人种族以及性别、性取向、基线时的保险状况和社区与轨迹分配有关;在某些轨迹中,随访期间的保险状况与每月依从性(≥6 剂/周)的几率有关。
在少数族裔中,大多数人能够持续坚持 PrEP 治疗。获得诊所、保险和交叉耻辱感可能是影响有效 PrEP 坚持的可改变的障碍;此外,需要关注年轻用户以及同性恋、顺性别群体以外的人群。